Skip to main content
TipRanks
Go Ultimate75% OFF

NRX Pharmaceuticals (B1Q) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

B1Q Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to NRX Pharmaceuticals in the past 3 months

B1Q Stock 12 Month Forecast

€32.74▲(1601.86% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for NRX Pharmaceuticals in the last 3 months. The average price target is EUR 32.74 with a high forecast of EUR 46.39 and a low forecast of EUR 10.91. The average price target represents a 1601.86% change from the last price of EUR 1.92.
Highest Price Target€46.39Average Price Target€32.74Lowest Price Target€10.91

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:B1Q
Price TargetArticle
BTIG€9.10→€10.91buy467.29%UpsideReiterated11/11/26
H.C. Wainwright€36.38→€40.93buy2027.33%UpsideReiterated11/09/26
Ascendiant€45.48→€46.39buy2310.97%UpsideReiterated11/01/26
Lucid Capital€44.57buy2216.42%UpsideInitiated05/13/26
D. Boral Capital€30.92buy1507.31%UpsideReiterated04/20/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
PTGXProtagonist Therapeutics
IMUXImmunic
IVAInventiva
PALIPalisade Bio

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering NRX Pharmaceuticals

3 Months
Edward Woo
Edward WooAscendiant
Success Rate6/13 ratings generated profit
46%
Average Return
-0.35%

Copying Edward Woo's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -0.35% per trade.

1 Year
Success Rate6/12 ratings generated profit
50%
Average Return
-3.21%

Copying Thomas Shrader's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -3.21% per trade.

2 Years
Edward Woo
Edward WooAscendiant
Success Rate6/13 ratings generated profit
46%
Average Return
-6.16%

Copying Edward Woo's trades and holding each position for 2 Years would result in 46.15% of your transactions generating a profit, with an average return of -6.16% per trade.

B1Q Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for B1Q
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy45779
Buy00000
Hold00000
Sell00000
Strong Sell00000
total45779

In the current month, B1Q has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. B1Q average Analyst price target in the past 3 months is 32.74.

B1Q Financial Forecast

€-2€-1.25€-0.5€0.25€1Q1 2026Q3 2026Q4 2026
High€-0.05
Consensus€-0.21
Low€-0.46

B1Q Earnings Forecast

Next quarter’s earnings estimate for B1Q is -EUR 0.21 with a range of -EUR 0.46 to -EUR 0.05. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€896,082€1.7M€2.5M€3.3M€4.1MQ1 2026Q3 2026Q4 2026
High€4.1M
Consensus€2.02M
Low€1.06M

B1Q Sales Forecast

Next quarter’s sales forecast for B1Q is EUR 2.02M with a range of EUR 1.06M to EUR 4.10M. The previous quarter’s sales results were EUR 1.06M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

B1Q Stock Forecast FAQ

What is DE:B1Q’s average 12-month price target, according to analysts?
Based on analyst ratings, NRX Pharmaceuticals’s 12-month average price target is €32.74.
What is DE:B1Q’s upside potential, based on the analysts’ average price target?
NRX Pharmaceuticals has 1601.86% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NRX Pharmaceuticals a Buy, Sell or Hold?
NRX Pharmaceuticals has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is NRX Pharmaceuticals’s share price target?
The average share price target for NRX Pharmaceuticals is €32.74. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €46.39, and the lowest forecast is €10.91. The average share price target represents a 1601.86% increase from the current price of €1.924.
What do analysts say about NRX Pharmaceuticals?
NRX Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of NRX Pharmaceuticals?
To buy shares of DE:B1Q, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.